HeraMED Limited (HMD.AX)

0.0170 0.0000 (0.00%) At close: 02:50PM AEST

HeraMED Limited

4 Hazoran Street
POB 8576
Netanya 4250604
Israel

https://www.hera-med.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D.	Executive Chairman	247.7k	N/A	N/A
Mr. Ido Toronchik	Chief Financial Officer	N/A	N/A	1983
Henry Jordan	Head of Investor Relations	N/A	N/A	N/A
Mr. Ariel Laden	Vice President of Marketing	N/A	N/A	N/A
Mr. Keith Koby BSEET, MBA	President of North America	N/A	N/A	N/A
Mr. Jonathan Hart B.Com., L.L.B.	Company Secretary	N/A	N/A	1984

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.

Corporate governance

HeraMED Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.